SMLL:ARCA-Direxiion Daily Small Cap Bull 2X Shares (USD)

ETF | Trading--Leveraged Equity | NYSE Arca

Last Closing

USD 22.015

Change

0.00 (0.00)%

Market Cap

USD 0.01B

Volume

100.00

Analyst Target

N/A
Analyst Rating

N/A

ducovest Verdict

Verdict

About

The investment seeks daily investment results, before fees and expenses, of 200% of the performance of the Russell 2000? Index. The fund, under normal circumstances, creates long positions by investing at least 80% of its assets in the securities that comprise the Russell 2000? Index and/or financial instruments that provide leveraged and unleveraged exposure to the index. The index measures the performance of the small-cap segment of the U.S. equity universe and is comprised of the smallest 2,000 companies in the Russell 3000? Index, representing approximately 8% of the total market capitalization of that index. The fund is non-diversified.

Inception Date: 29/07/2014

Primary Benchmark: Russell 2000 TR USD

Primary Index: S&P 500 TR USD

Gross Expense Ratio: 1.52%

Management Expense Ratio: 0.28 %

Unadjusted Closing Price

Adjusted Closing Price

Assets

N/A

Top Holdings

N/A

Symbol Company Name Allocation
TARS Tarsus Pharmaceuticals Inc 3.01 %
Top Sectors

N/A

Top Regions

N/A

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2025-01-04 )

Largest Industry Peers for Trading--Leveraged Equity

Symbol Name Mer Price(Change) Market Cap
SOXL Direxion Daily Semiconductor B.. 1.10 %

+2.67 (+8.95%)

USD 9.92B
FNGU MicroSectors FANG+ Index 3X Le.. 0.00 %

+32.36 (+5.26%)

USD 7.96B
QLD ProShares Ultra QQQ 0.95 %

+2.53 (+2.27%)

USD 7.84B
SSO ProShares Ultra S&P500 0.90 %

+1.12 (+1.19%)

USD 5.60B
UPRO ProShares UltraPro S&P500 0.92 %

+1.58 (+1.73%)

USD 4.27B
TECL Direxion Daily Technology Bull.. 1.17 %

+3.61 (+3.83%)

USD 3.43B
YINN Direxion Daily FTSE China Bull.. 1.02 %

-0.98 (-3.55%)

USD 1.61B
USD ProShares Ultra Semiconductors 0.95 %

+4.15 (+5.77%)

USD 1.16B
UDOW ProShares UltraPro Dow30 0.95 %

-0.04 (-0.04%)

USD 0.91B
LABU Direxion Daily S&P Biotech Bul.. 1.14 %

-0.46 (-0.48%)

USD 0.82B

ETFs Containing SMLL

N/A

Market Performance

  Market Performance vs. Industry/Classification (Trading--Leveraged Equity) Market Performance vs. Exchange (NYSE Arca)
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 1.18% 37% F 62% D
Dividend Return N/A N/A N/A N/A N/A
Total Return 1.18% 37% F 61% D-
Trailing 12 Months  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Trailing 5 Years  
Capital Gain -58.16% 27% F 8% B-
Dividend Return N/A N/A N/A N/A N/A
Total Return -58.16% 24% F 6% D-
Average Annual (5 Year Horizon)  
Capital Gain 7.16% 21% F 58% F
Dividend Return 7.21% 18% F 50% F
Total Return 0.06% 3% F 3% F
Risk Return Profile  
Volatility (Standard Deviation) 107.20% 36% F 8% B-
Risk Adjusted Return 6.73% 13% F 25% F
Market Capitalization 0.01B N/A N/A N/A N/A

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:
Poor risk adjusted returns

This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.

Below median dividend returns

The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.

Below median total returns

The company has under performed its peers on annual average total returns in the past 5 years.

High volatility

The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.